US ramps up third-country deportations and PEPFAR cuts—Africa braces for a double shock

The United States is preparing to send “third-country” deportees to the Central African Republic, according to Reuters and SCMP citing sources familiar with the matter. The Central African Republic has reportedly agreed to take in migrants removed by the US from other countries, framed as part of a Trump administration push to accelerate removals through deals with African states. In parallel, reporting from NPR and a separate outlet describes health-care providers in South Africa and Mozambique warning that cancellation or redirection of US PEPFAR funding under the Trump administration has already endangered vulnerable people and cost lives. The articles tie the policy shift to on-the-ground disruptions in HIV/AIDS care delivery, with clinics facing sudden uncertainty over staffing, supplies, and patient continuity. Geopolitically, the cluster highlights a dual-use leverage strategy: migration enforcement and foreign assistance are being used together to reshape partner-country behavior and domestic outcomes. For Washington, third-country agreements can reduce political friction at home while externalizing removal logistics to willing partners; for Central African Republic authorities, the deal may bring resources or political engagement but also reputational and humanitarian risks. For South Africa and Mozambique, the PEPFAR funding shift signals a recalibration of US health diplomacy, potentially weakening influence in a sector where the US has historically been a major backstop. The power dynamic is asymmetric: African states may negotiate terms, but the operational burden of service disruption falls on local health systems and affected communities. Market and economic implications are indirect but real, particularly through health-sector stability, NGO and contractor cash flows, and risk premia for frontier-country operations. In South Africa and Mozambique, disruptions to HIV/AIDS treatment continuity can increase long-run healthcare costs and labor productivity losses, while also pressuring government budgets already strained by broader fiscal constraints. For investors, the most immediate signals are in development-finance expectations and the stability of supply chains for medical commodities tied to HIV programs, including antiretroviral therapies and related diagnostics. Currency and sovereign risk may not move on day one, but sustained funding uncertainty can worsen perceptions of policy volatility and governance capacity, especially in countries where donor dependence is high. What to watch next is whether the US provides clarity on the scale, timing, and legal basis of PEPFAR cancellations or redirections, and whether partner governments receive compensatory funding or technical support. On migration, the key trigger is implementation: the first arrivals of third-country deportees to the Central African Republic, any reported detention conditions, and whether additional African states are added to the framework. For health, monitor clinic-level indicators such as appointment backlogs, ART stockouts, and reported mortality or treatment interruption rates, alongside any emergency mitigation announcements by local ministries. Escalation would be signaled by widening public-health disruptions or diplomatic friction over humanitarian standards, while de-escalation would come from phased transitions, carve-outs for life-saving treatment, and transparent reporting of program continuity.

Geopolitical Implications

• 01

  Migration deals are being used to reshape partner-country behavior while shifting logistical burdens abroad.

• 02

  Abrupt aid transitions can weaken US health-diplomacy influence and create space for alternative donors.

• 03

  Humanitarian fallout from health funding disruptions can trigger diplomatic pushback and constrain future cooperation.

Key Signals

• —US clarity on PEPFAR cancellation/redirection scope, timing, and legal basis.
• —First implementation milestones for third-country deportees to the Central African Republic.
• —Clinic-level ART continuity indicators (stockouts, appointment backlogs, treatment interruptions).
• —Partner-government statements on humanitarian standards and any compensatory support.